http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009091597-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63b44d6161589e473edf6d4797cdb756
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0625
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-15
filingDate 2009-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ba287436a39717001a73541a004806b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1fb28771f5bd9733195511230070dc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_095d8205caab1cf66c273aa64041355f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d4ed1ca015cb626ae879fb66352f04e
publicationDate 2009-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009091597-A2
titleOfInvention Treatments of disease or disorders using nanoparticles for focused hyperthermia to increase therapy efficacy
abstract Methods are provided for the treatment of diseases and disorders using systematically-introduced nanoparticles to create a focused localized hyperthermia in a target area to enhance the effect of additional treatment therapies such as ionizing radiation. Advantages include an enhancement of the therapeutic effect of other therapies by increasing perfusion or reducing hypoxia in the treatment area, further, the methods herein may also result in the disruption of the vasculature, which provide further impetus for such treatments, singly and in combination with conventional therapies such as chemotherapy and radiation therapy. Methods for treating a target area may comprise systemically introducing nanoparticles into an organism; allowing the nanoparticles to preferentially accumulate in the target area, applying an external energy where the nanoparticles are adapted to transduce at least a portion of the external energy into a heal energy so as to create a focused localized hyperthermia; and applying a subsequent additional therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013087920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3130351-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011137514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014054884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8337433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9968688-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015056960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2468447-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11433105-B2
priorityDate 2008-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44258291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66590144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226446612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID335929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226484278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226446613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5351387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136046180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135974690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129641888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129859949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18645713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136010750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129685900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205

Total number of triples: 71.